Nicotinyl methylamide
![]() | |
![]() | |
| Names | |
|---|---|
| Preferred IUPAC name N-Methylpyridine-3-carboxamide | |
| Other names N-Methylnicotinamide; N-Methylniacinamide | |
| Identifiers | |
3D model (JSmol) | |
| Abbreviations | NAN |
| ChEBI | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.003.679 |
| EC Number |
|
| MeSH | C008472 |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C7H8N2O | |
| Molar mass | 136.154 g·mol−1 |
| Pharmacology | |
| A05AB01 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Nicotinyl methylamide is an experimental drug with no approved indication.[1] It is also a metabolite of nicotinamide (vitamin B3) and is found in urine.[2]
See also
References
- ^ "N-methylnicotinamide". DrugBank.
- ^ "Nicotinyl methylamide". Inxight Drugs. National Center for Advancing Translational Sciences.

